Practical Patient Care Weekly

Welcome to another edition of the Practical Patient Care newsletter!

Discover the latest insights and analyses from the global healthcare market over the past week, brought to you by Practical Patient Care

Health Recovery Solutions (HRS) partners with Smart Meter, LLC to enhance PatientConnect RPM solution.

Integrating cellular measurement devices offers a cost-effective alternative to Bluetooth-based systems, making healthcare more accessible for patients and providers.

Health Recovery Solutions CEO Jason Comer said: “Our goal has always been to make healthcare more accessible and affordable for everyone.“ By partnering with Smart Meter, we are able to offer a more flexible, easy-to-use, and cost-effective solution that caters to the needs of our diverse patient population.

This collaboration represents a significant step forward in our mission to improve patient outcomes and reduce healthcare costs.”

Read more on this: https://lnkd.in/eU4jpbM2

Microbix Biosystems Inc . has achieved crucial European Union regulatory accreditations for its diagnostic assay quality assessment products (QAPs).

Microbix has achieved EU IVDR compliance and CE Certification for 11 REDx QAPs. This milestone ensures full access to EU markets, validating our development processes and enabling continued growth. Our QAPs support crucial diagnostic assays across various applications

https://lnkd.in/euaygemK

Exciting news in the biotech world! Bruker has acquired Bruker Biosensors , a pioneer in single-cell interaction cytometry systems for drug discovery.

This strategic move combines Dynamic Biosensors' innovative heliX series with Bruker's high-performance SPR portfolio, creating a leading biosensors business.

Dr. Meike Hamester, VP of Bruker Biosensors, stated: "This strategic acquisition enhances Bruker's position in the pharma and biotech industries... establishing a new technology leader in biosensors with a differentiated offering."

Dynamic Biosensors co-founders Dr. Ralf Strasser and Professor Ulrich Rant added: "We are excited to work with our new colleagues to further develop a unique and differentiated biosensor business."

The acquisition strengthens Bruker's capabilities in analysing molecular interactions and kinetics, offering deeper insights for drug discovery and research. With enhanced technologies and a broader product range, Bruker is poised to deliver cutting-edge solutions to the pharmaceutical and biotechnology industries.

https://lnkd.in/gPwC9b44

?? Smith+Nephew and JointVue, LLC collaborate on robotics-assisted surgery.

The co-marketing agreement is focused on JointVue’s patented OrthoSonic 3D Surgery Planning Technology. OrthoSonic is said to be the only ultrasound device available for 3D preoperative planning.

The partnership will allow the integration of JointVue’s technology with Smith+Nephew’s CORI Surgical System.

Surgeons using the CORI Surgical System with OrthoSonic 3D Surgery Planning Technology for robotic-assisted knee surgery will help to create personalised surgical plans.

Read more online: https://lnkd.in/e_Q-ZQXE

Seegene Inc. , a South Korean PCR molecular diagnostics provider, has finalized a partnership agreement with Werfen a specialized diagnostics firm, to establish a joint venture called Werfen-Seegene in Spain.

This collaboration is part of Seegene's global technology-sharing initiative, which aims to share its advanced diagnostic and data analysis technologies with partners worldwide.

The new company will focus on developing products for infectious diseases, including antimicrobial resistance testing, viral load testing, and monitoring for organ transplant patients. It will leverage Werfen's local infrastructure and Seegene's technology to create diagnostic solutions tailored to Spain's healthcare needs.

Carlos Pascual, CEO of Werfen, expressed excitement about the partnership, stating, "We are excited to leverage Seegene's unparalleled technology and manufacturing expertise to develop products tailored for the Spanish and Portuguese market, where there is a high demand for rapid product development due to the frequent emergence of new infectious diseases and viral mutations."

This joint venture, expected to be established by mid-2025 pending regulatory approvals, will serve as a strategic hub in Europe, accelerating the global expansion of Seegene's technology-sharing initiative.

The partnership aims to enhance local product development capabilities and address specific healthcare challenges in Spain and beyond. Read more on this: https://lnkd.in/eXPHEyfw

WEBINAR ALERT!

???? Join Practical Patient Care and Bruker ? Microbiology & Infection Diagnostics for the upcoming webinar "Diagnostic tools for Hepatitis B screening, management and follow up"

Why attend?

Chronic hepatitis B virus (HBV) infection is a major public health problem and a cause of chronic liver disease leading to an estimated 1.1 million deaths in 2022, mainly due to cirrhosis and hepatocellular carcinoma (HCC).

In 2022, World Health Organization estimated that 254 million people were living with chronic hepatitis B, of whom 65% were in the African and Western Pacific regions.

Most of this global burden can be attributed to mother to child transmission (MTCT) at the time of or shortly after birth and horizontal household transmission.

Register here: https://lnkd.in/eWf-Kwi7

To have a story featured on next week's newsletter, or require press and marketing support you can contact our team directly...

Editorial Enquiries - [email protected]

Press & Marketing support - [email protected]

Thanks for reading; we hope you enjoyed it.

Until next week.